Ann: Results from Data Confirmation Study, page-173

Remarkable the number of new posters suddenly appearing with a ‘Not Held’ sentiment telling us we should get out. I do hope no one is paying them. I can’t think of anyone who would. Can you?

The Delta strain gives a lower respiratory tract effect. The Omicron is an upper respiratory matter. The first trial was undertaken with the former dominant. The second undertaken with the latter dominant. If they have simply combined the two no wonder there is a reduction in the result.

RapDX differentiates between lower respiratory and upper respiratory. This is it’s primary value.

Pfizer’s offer was not dependent on the result. It was the offer price that was dependent on the result. They are still offering to take our shares off our hands for us.

Put all the above together and see if you come up with anything.

poorinvestor